Table 1 Resistance profiles of  $ E.\ coli $  isolated from poultry (P), their farmers (F) and patients (C)



<table><tr><td>Antibiotics</td><td colspan="3">Origin of isolates</td><td colspan="3">P</td></tr><tr><td></td><td>Poultry (n=70) n (%)</td><td>Farmers (n=70) n (%)</td><td>Clinical samples (n=94) n (%)</td><td>P vs F</td><td>P vs C</td><td>F vs C</td></tr><tr><td>Amoxicillin</td><td>55 (78.5)</td><td>10 (14.3)</td><td>93 (98.9)</td><td>&lt;0.001</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td>Ticarcillin</td><td>55 (78.5)</td><td>10 (14.3)</td><td>93 (98.9)</td><td>&lt;0.001</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td>Piperacillin</td><td>3 (4.3)</td><td>0 (0)</td><td>92 (97.8)</td><td>NS</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td>Amoxicillin/clavulanic acid</td><td>0 (0)</td><td>0 (0)</td><td>76 (80.8)</td><td>NS</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td>Ticarcillin/clavulanic acid</td><td>2 (2.9)</td><td>1 (1.4)</td><td>83 (88.3)</td><td>NS</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td>Piperacillin/tazobactam</td><td>0 (0)</td><td>1 (1.4)</td><td>8 (8.5)</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>Cefalotin</td><td>0 (0)</td><td>0 (0)</td><td>88 (93.6)</td><td>NS</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td>Cefamandole</td><td>3 (4.3)</td><td>0 (0)</td><td>90 (95.7)</td><td>NS</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td>Ceftazidime</td><td>0 (0)</td><td>0 (0)</td><td>78 (82.9)</td><td>NS</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td>Cefotaxime</td><td>0 (0)</td><td>0 (0)</td><td>87 (92.5)</td><td>NS</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td>Cefepime</td><td>0 (0)</td><td>0 (0)</td><td>76 (80.8)</td><td>NS</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td>Cefoxitin</td><td>0 (0)</td><td>0 (0)</td><td>17 (18.1)</td><td>NS</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td>Cefixime</td><td>0 (0)</td><td>0 (0)</td><td>82 (87.2)</td><td>NS</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td>Aztreonam</td><td>0 (0)</td><td>0 (0)</td><td>84 (89.3)</td><td>NS</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td>Mecillinam</td><td>16 (22.8)</td><td>3 (4.3)</td><td>68 (72.3)</td><td>0.002</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td>Moxalactam</td><td>0 (0)</td><td>0 (0)</td><td>0 (0)</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>Ertapenem</td><td>0 (0)</td><td>0 (0)</td><td>1 (1.1)</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>Imipenem</td><td>0 (0)</td><td>0 (0)</td><td>0 (0)</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>Meropenem</td><td>0 (0)</td><td>0 (0)</td><td>0 (0)</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>Amikacin</td><td>0 (0)</td><td>0 (0)</td><td>4 (4.2)</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>Netilmicin</td><td>0 (0)</td><td>0 (0)</td><td>29 (30.8)</td><td>NS</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td>Tobramycin</td><td>0 (0)</td><td>0 (0)</td><td>62 (65.9)</td><td>NS</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td>Gentamicin</td><td>0 (0)</td><td>0 (0)</td><td>54 (57.4)</td><td>NS</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td>Nalidixic acid</td><td>62 (88.7)</td><td>11 (15.7)</td><td>75 (79.7)</td><td>&lt;0.001</td><td>NS</td><td>&lt;0.001</td></tr><tr><td>Ofloxacin</td><td>56 (80)</td><td>8 (11.4)</td><td>74 (78.7)</td><td>&lt;0.001</td><td>NS</td><td>&lt;0.001</td></tr><tr><td>Ciprofloxacin</td><td>36 (51.4)</td><td>4 (5.7)</td><td>70 (74.4)</td><td>&lt;0.001</td><td>0.003</td><td>&lt;0.001</td></tr><tr><td>Minocycline</td><td>8 (11.4)</td><td>0 (0)</td><td>32 (34.1)</td><td>&lt;0.001</td><td>0.001</td><td>&lt;0.001</td></tr><tr><td>Cotrimoxazole</td><td>58 (82.8)</td><td>9 (12.9)</td><td>80 (85.1)</td><td>&lt;0.001</td><td>NS</td><td>&lt;0.001</td></tr><tr><td>Nitrofurantoin</td><td>2 (2.9)</td><td>2 (2.9)</td><td>2 (2.1)</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>Fosfomycin</td><td>0 (0)</td><td>0 (0)</td><td>0 (0)</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>Colistin</td><td>0 (0)</td><td>0 (0)</td><td>0 (0)</td><td>NS</td><td>NS</td><td>NS</td></tr></table>

and fecal samples were almost identical to resistant isolates from geographically linked chickens, whereas drug-susceptible human  $ E.\ coli $  strains were genetically distinct from avian ones, suggesting a possible dissemination via the poultry.  $ E.\ coli $  strains could also be transmitted from poultry to humans through meat consumption and environmental contamination with manure or faeces of wild or domestic birds [21, 22]. Another route of antimicrobial-resistant  $ E.\ coli $  entry into the community is through occupational exposure to  $ E.\ coli $  from live-animal contact in the broiler chicken industry [23]. This had been confirmed by our findings, as we observed clonality between chicken and chicken farmers’ strains, and between the latter and human pathogenic ones.

The sporadic nature and the appearance of new pathogenic  $ E.\ coli $  strains by virtue of novel STs suggests that these strains may be commensal that have acquired the antibiotic resistance encoding plasmids (especially ESBL) [24]. This is in agreement with our findings, as we observed clonality between a  $ bla_{CTX-M-15}^{+} $  ExPEC strain and one chicken-farmer commensal strain and another  $ bla_{CTX-M-15}^{+} $  ExPEC strain with two chicken commensal ones (Fig. 1). Acquisition of resistance genes may also account for the differences in drug resistance between our clonal avian–human strains and clonal commensal–pathogenic strains, as the drug selection pressure in clinical environments is the major cause of the accumulation of resistance determinants against antibiotics. According to

